Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) insider Christopher K. Murray sold 5,000 shares of Blueprint Medicines stock in a transaction on Thursday, December 7th. The shares were sold at an average price of $75.00, for a total value of $375,000.00. Following the completion of the transaction, the insider now owns 24,495 shares in […]
DA Davidson started coverage on shares of BellRing Brands (NYSE:BRBR – Free Report) in a report published on Friday morning, Marketbeat.com reports. The brokerage issued a neutral rating and a $60.00 target price on the stock. Several other research firms also recently commented on BRBR. Barclays lifted their price target on shares of BellRing Brands […]
Vanguard Industrials ETF (NYSEARCA:VIS – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $213.26 and last traded at $213.24, with a volume of 41928 shares changing hands. The stock had previously closed at $211.86. Vanguard Industrials ETF Stock Up 0.5 % The company […]
Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the target of a large drop in short interest in November. As of November 15th, there was short interest totalling 4,170,000 shares, a drop of 6.3% from the October 31st total of 4,450,000 shares. Based on an average daily trading volume, of 634,700 shares, the short-interest […]
Ameritas Investment Partners Inc. reduced its position in BellRing Brands, Inc. (NYSE:BRBR – Free Report) by 0.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 44,242 shares of the company’s stock after selling 318 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in […]